House Bill 434, titled “Lower Healthcare Costs,” is a broad healthcare transparency and consumer-protection measure affecting hospitals, ambulatory surgical facilities, insurers, healthcare providers, and the State Health Plan. It expands price-disclosure requirements for hospitals and ambulatory surgical facilities, including reporting of charges, negotiated amounts, Medicaid and Medicare reimbursement, and payment ranges from major insurers for common inpatient, surgical, and imaging services. It also requires facilities to provide patients, upon request, with written pricing information and quality measures, and it authorizes civil penalties for noncompliance.
The bill also creates new notice requirements for patients receiving care from out-of-network facilities or providers, requires good-faith estimates for shoppable services, limits final bills to within 5% of the estimate when requested, and restricts certain facility fees. In addition, it tightens billing and collections practices by requiring itemized bills before referral to collections, updates prior authorization and utilization review rules for insurers, and bars the use of artificial intelligence as the sole basis for a utilization review denial. The bill further eliminates certificate-of-need review for inpatient rehabilitation services, rehabilitation facilities, and rehabilitation beds, and directs the State Auditor to review pricing practices at certain state-funded facilities.
The bill’s impact on state law is substantial: it rewrites major portions of Chapter 131E governing healthcare cost transparency, creates a new Article on fair billing and collections, amends insurance utilization review statutes in Chapter 58, and modifies the State Auditor’s duties in Chapter 147. It also imposes new reporting, disclosure, and enforcement obligations on hospitals, ambulatory surgical facilities, health systems, insurers, and providers, while creating new consumer rights related to estimates, network disclosures, and billing practices. Several provisions are tied to rulemaking by the Department of Health and Human Services or the North Carolina Medical Care Commission and take effect later than enactment.
The general sentiment reflected in the bill text and voting history is strongly favorable toward the bill’s stated goal of lowering costs and increasing transparency. The measure passed second reading in both chambers by wide margins, with only a small number of dissenting votes and unanimous concurrence on the later Senate motion not to concur. The bill’s findings frame healthcare pricing as a major burden on patients, employers, and taxpayers, and the structure of the legislation reflects a policy preference for disclosure, consumer choice, and market pressure on prices.
Notable points of contention are likely to center on the breadth and administrative burden of the new reporting and disclosure requirements, the facility-fee restrictions, and the new enforcement mechanisms, including unfair-and-deceptive-trade-practice treatment and civil penalties. Insurers and providers may also object to the shortened timelines for prior authorization decisions, the expanded notice obligations for out-of-network care, and the limits on billing practices. The elimination of certificate-of-need review for rehabilitation services may also be controversial because it changes market-entry rules and could affect existing providers and facility planning.
The bill substantially amends North Carolina law by expanding healthcare price transparency requirements, creating new billing and collections standards, and revising insurance utilization review and prior authorization rules. It adds new statutory duties for hospitals, ambulatory surgical facilities, health systems, insurers, and healthcare providers, while also changing the State Auditor’s oversight responsibilities and removing certificate-of-need review for certain rehabilitation-related facilities and beds. The bill creates new enforcement tools, including civil penalties and unfair-and-deceptive-trade-practice liability, and many provisions depend on future rulemaking and delayed effective dates.
The overall sentiment appears strongly supportive of the bill’s consumer-protection and cost-reduction goals. The bill’s findings and title emphasize affordability, transparency, and patient empowerment, and the voting record shows overwhelming approval in both chambers with only minimal opposition. No committee transcript is available, but the recorded votes suggest broad bipartisan acceptance of the measure’s general direction.
Likely points of contention include the compliance burden on hospitals, ambulatory surgical facilities, insurers, and providers; the scope of required public reporting; and the new penalties for noncompliance. Providers and health systems may object to limits on facility fees, mandatory good-faith estimates, and the requirement to disclose network status and billing risks, while insurers may resist the tighter prior authorization timelines and the prohibition on using AI as the sole basis for denial. The repeal of certificate-of-need review for rehabilitation services may also draw concern from existing providers and regulators who favor controlled expansion.